glp-1 glp-2 dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Endocrine Research Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support Use of DPP-4 inhibitors

glp-1 glp-2 dual agonist and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Endocrine Research Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support Use of DPP-4 inhibitors

Use of DPP-4 inhibitors and GLP-1 receptor agonists

It is important to note that including patients with a known history of depression and/or anxiety in such studies could bias the results, as these patients are more prone to experience a new episode, which could be wrongfully attributed to GLP-1 RAs drugs

Endocrine Research

Items included:Daily Fiber+ | Daily Cortisol Support | GLP-1 Support

In clinical trial results released in December 2025, people on the highest dose of retatrutide lost nearly 30 percent of their body weight in 68 weeks